"a failed phase III"? Study is continuing or ongoing, not recruiting more participants. Ethics requires following those who have not evented or otherwise disappeared.
The Sunrise trial is as dead as can be. PPHM can continue to monitor those who were treated in the trial, and people who were treated with Bavi were given the option to continue being treated. That is it. The trial is, dead, dead, dead. This is basic biotech investing 101 so any failure to accept that reality is very telling. Whether or not you feel than Bavi has some life left in it as part of some immune modulation combination is a completely separate issue.